Antibiotic use and inflammatory bowel disease: number needed to harm? Authors' reply

被引：0
|
作者：
Faye, Adam S. [1 ,2 ,4 ]
Jess, Tine [2 ,3 ]
机构：
[1] New York Univ, Dept Med & Populat Hlth, Grossman Sch Med, New York, NY USA
[2] Aalborg Univ, Ctr Mol Predict Inflammatory Bowel Dis, Dept Clin Med, Copenhagen, Denmark
[3] Aalborg Univ, Dept Gastroenterol & Hepatol, Aalborg, Denmark
[4] New York Univ, Grossman Sch Med, New York, NY 10016 USA
来源：
GUT | 2023年
关键词：
IBD; ANTIBIOTICS; CROHN'S DISEASE; ULCERATIVE COLITIS;
D O I：
10.1136/gutjnl-2023-329851
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply
    Chapman, Thomas P.
    Frias Gomes, Catarina
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (10) : 1621 - 1621
  • [22] Associations between the IGF system and inflammatory markers in inflammatory bowel disease: authors' reply
    Gentilucci, UV
    Picardi, A
    Caviglia, R
    Cicala, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (04) : 554 - 555
  • [23] Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease: authors' reply
    Jakobsen, C.
    Bartek, J., Jr.
    Wewer, V.
    Vind, I.
    Munkholm, P.
    Groen, R.
    Paerregaard, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (03) : 392 - 393
  • [24] Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' reply
    Fairbrass, Keeley M.
    Hamlin, P. John
    Gracie, David J.
    Ford, Alexander C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) : 1302 - 1303
  • [25] Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply
    Vasudevan, Abhinav
    Con, Danny
    van Langenberg, Daniel R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (06) : 794 - 794
  • [26] Letter: causes of fatigue in inflammatory bowel disease remain uncertain - authors' reply
    Artom, M.
    Czuber-Dochan, W.
    Norton, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (05) : 763 - 764
  • [27] ASSOCIATION BETWEEN ANTIBIOTIC USE AND INFLAMMATORY BOWEL DISEASE OUTCOMES
    Liu, Luke
    O'Charoen, Sirimon
    Fehlmann, Tara
    Roedder, Silke
    Wendt, Emily
    Billin, Andrew
    Younis, Islam
    Iqbal, Shahed
    GASTROENTEROLOGY, 2023, 164 (04) : S42 - S42
  • [28] Pulse cyclophosphamide in steroid-resistant inflammatory bowel disease: authors' reply
    Creed, T. J.
    Probert, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (11) : 1364 - 1364
  • [29] Letter: screening for adrenal suppression in paediatric inflammatory bowel disease - authors' reply
    Philpott, Hamish
    Dougherty, Michael K.
    Dellon, Evan S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (08) : 885 - 886
  • [30] Letter: psychological remission - a future endpoint in inflammatory bowel disease? Authors' reply
    Panara, A. J.
    Yarur, A. J.
    Sussman, D. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (12) : 1436 - 1437
12345